Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active reference
Article website: https://pubmed.ncbi.nlm.nih.gov/40209740/ Citation: Ward, C., Milovančević, M.P., Kohegyi, E., [...]